Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

International Nursing Organizations II01:28

International Nursing Organizations II

1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Transitioning from Laboratory-Developed Tests to a Single Commercial Reagent Kit in a National Newborn Screening Program: Impact on Analytical Performance and Harmonization.

International journal of neonatal screening·2026
Same author

The Variation in IRT in Different Ethnic Groups in England-Implications for a Newborn Screening Programme for CF in Diverse Multiethnic Populations.

International journal of neonatal screening·2026
Same author

Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews.

Health technology assessment (Winchester, England)·2025
Same author

Challenges in evaluating whole genome sequencing for newborn screening: series of systematic reviews and roadmap for evidence generation for policy advisers.

BMJ medicine·2025
Same author

Methodological and Procedural Considerations for Developing Decision Analytic Models to Assess the Health Economic Impacts of Newborn Bloodspot Screening: A Systematic Methodological Review.

International journal of neonatal screening·2025
Same author

Learning Collaborative to Support Continuous Quality Improvement in Newborn Screening.

International journal of neonatal screening·2025
Same journal

Health Outcomes of Patients with Distal Urea Cycle Disorders Detected by Newborn Screening: Data from the Spanish National Registry.

International journal of neonatal screening·2026
Same journal

Ethical and Clinical Boundaries in Genomics & Newborn Screening: A Brief Report from IPIC2025.

International journal of neonatal screening·2026
Same journal

Implementation of a Prospective Birth Cohort for Newborn Screening and Early Linkage to Comprehensive Sickle Cell Disease Care in a Low-Resource Setting.

International journal of neonatal screening·2026
Same journal

Development of Dried Blood Spot Proficiency Testing Materials for Newborn Screening of Lysosomal Diseases Using Recombinant Enzymes.

International journal of neonatal screening·2026
Same journal

A Four-Year Prospective Pilot Study of Newborn Screening for Late-Onset Proximal Urea-Cycle Disorders in Hyogo Prefecture in Japan.

International journal of neonatal screening·2026
See all related articles

Related Experiment Video

Updated: Jul 12, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.0K

2023 APHL/ISNS Newborn Screening Symposium.

Richard S Olney1, James R Bonham2, Peter C J I Schielen3

  • 1Genetic Disease Screening Program, California Department of Public Health, Richmond, CA 94804, USA.

International Journal of Neonatal Screening
|October 24, 2023
PubMed
Summary
This summary is machine-generated.

The 2023 APHL/ISNS Newborn Screening Symposium showcased advancements in newborn screening (NBS) technologies and practices. Key findings highlighted improved diagnostic capabilities and expanded screening panels for early detection of genetic disorders.

Keywords:
APHLISNSnewborn screening

More Related Videos

State of the Art Cranial Ultrasound Imaging in Neonates
10:02

State of the Art Cranial Ultrasound Imaging in Neonates

Published on: February 2, 2015

24.4K
Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays
10:43

Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays

Published on: July 20, 2017

8.9K

Related Experiment Videos

Last Updated: Jul 12, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.0K
State of the Art Cranial Ultrasound Imaging in Neonates
10:02

State of the Art Cranial Ultrasound Imaging in Neonates

Published on: February 2, 2015

24.4K
Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays
10:43

Developing HiPSC Derived Serum Free Embryoid Bodies for the Interrogation of 3-D Stem Cell Cultures Using Physiologically Relevant Assays

Published on: July 20, 2017

8.9K

Area of Science:

  • Public Health
  • Genetics
  • Biochemistry

Background:

  • The 2023 APHL/ISNS Newborn Screening Symposium convened experts to discuss the latest developments in newborn screening.
  • The symposium focused on enhancing early detection of congenital disorders through innovative screening methods.

Framework:

  • The event highlighted advancements in analytical techniques for expanded newborn screening panels.
  • Discussions centered on optimizing screening protocols and laboratory workflows for improved efficiency and accuracy.

Implementation:

  • Presentations covered the implementation of new screening technologies and genetic testing methodologies.
  • Case studies demonstrated successful integration of novel screening approaches into public health programs.

Implications:

  • The symposium underscored the critical role of newborn screening in preventing lifelong disabilities and improving child health outcomes.
  • Future directions emphasized the potential of precision medicine and tailored screening strategies for diverse populations.